|
Mr. Fotiades has served as a Trustee since 2001. He is Chairman of the Healthcare investment practice at Diamond Castle Holdings, a private equity investment firm that works in partnership with management teams to execute leveraged buyouts and make growth capital and equity-like investments in public and private companies.
Prior to joining Diamond Castle in 2007, Mr. Fotiades was President and Chief Operating Officer of Cardinal Health, Inc., the Fortune 20 leading provider of products and services supporting the health care industry. Prior to that position, he served as President and CEO of Cardinal's Pharmaceutical Technologies and Services segment, the largest provider of contract manufacturing and packaging services to the pharmaceutical industry. Previously, he served in a variety of executive roles, including President of Warner-Lambert's consumer healthcare business and senior positions at Bristol-Myers Squibb, Wyeth and Procter and Gamble.
Mr. Fotiades is non-executive Chairman of Catalent Pharma Solutions (the former Pharmaceutical Technologies and Services segment of Cardinal), and a Director of the Alberto-Culver Company (NYSE: ACV). He holds an A.B. from Amherst College and an M.M. from The Kellogg School of Management at Northwestern University. | 